TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,957 | -55.2% | 5,258 | +33.2% | 0.02% | -54.2% |
| Q2 2023 | $98,019 | +46.6% | 3,946 | -11.2% | 0.05% | +33.3% |
| Q1 2023 | $66,868 | +32.3% | 4,446 | +4.1% | 0.04% | +24.1% |
| Q4 2022 | $50,538 | +53.1% | 4,272 | -24.2% | 0.03% | +52.6% |
| Q3 2022 | $33,000 | +65.0% | 5,634 | +20.6% | 0.02% | +58.3% |
| Q2 2022 | $20,000 | -58.3% | 4,672 | -7.5% | 0.01% | -50.0% |
| Q1 2022 | $48,000 | -50.0% | 5,052 | 0.0% | 0.02% | -46.7% |
| Q4 2021 | $96,000 | -45.1% | 5,052 | -3.7% | 0.04% | -58.7% |
| Q3 2021 | $175,000 | -19.7% | 5,244 | -6.7% | 0.11% | -18.7% |
| Q2 2021 | $218,000 | -22.1% | 5,622 | -3.3% | 0.13% | -35.0% |
| Q1 2021 | $280,000 | +976.9% | 5,815 | +1042.4% | 0.21% | +881.0% |
| Q4 2020 | $26,000 | – | 509 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |